Recently, Messner et al. [60] indicated that p.G13D mutated CRC cells are more sensitive to anti-EGFR treatment than codon 12-or codon 61-mutated cells and the p.G13D-mutated CRC cells seem to define a less aggressive phenotype. Here, EGFR is linked to colorectal carcinoma.